Journal
TRANSLATIONAL NEUROSCIENCE IN PSYCHIATRY
Volume 1344, Issue -, Pages 66-77Publisher
BLACKWELL SCIENCE PUBL
DOI: 10.1111/nyas.12718
Keywords
ketamine; depression; antidepressant; treatment mechanisms; neurobiology
Categories
Funding
- Brain and Behavior Research Foundation (NARSAD)
- American Psychiatric Foundation
- Genentech
Ask authors/readers for more resources
The discovery of ketamine's rapid and robust antidepressant effects opened a window into a new generation of antidepressants. Multiple controlled trials and open-label studies have demonstrated these effects across a variety of patient populations known to often achieve little to no response from traditional antidepressants. Ketamine has been generally well tolerated across patient groups, with transient mild-to-moderate adverse effects during infusion. However, the optimal dosing and route of administration and the safety of chronic treatment are not fully known. This review summarizes the clinical effects of ketamine and its neurobiological underpinnings and mechanisms of action, which may provide insight into the neurobiology of depression, relevant biomarkers, and treatment targets. Moreover, we offer suggestions for future research that may continue to advance the field forward and ultimately improve the psychopharmacologic interventions available for those individuals struggling with depressive and trauma-related disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available